Foundational Science and Mechanisms of Disease

426 questions

Question 101Question →

A 3232-year-old industrial worker is brought to the emergency department after losing consciousness in a metal plating facility. Coworkers report a chemical spill occurred shortly before he collapsed. On examination, he is comatose with a respiratory rate of 2828/min and a heart rate of 120120/min. His skin appears flushed. A faint "bitter almond" odor is noted on his clothing. Arterial blood gas analysis on room air reveals:

ParameterPatient ValueReference Range
pH7.127.127.35−7.457.35 - 7.45
pCO2_22424 mmHg35−4535 - 45 mmHg
pO2_29898 mmHg80−10080 - 100 mmHg
HCO3−_3^-88 mEq/L22−2822 - 28 mEq/L
Lactate14.514.5 mmol/L0.5−1.00.5 - 1.0 mmol/L

Which of the following describes the primary subcellular mechanism responsible for this patient's profound cellular injury?

Show answer & explanation

Answer: Inhibition of mitochondrial cytochrome c oxidase by binding to its ferric iron component, preventing oxygen reduction.

Answer

Inhibition of mitochondrial cytochrome c oxidase by binding to its ferric iron component, preventing oxygen reduction.
The clinical presentation of rapid-onset coma, severe lactic acidosis, normal arterial oxygen tension, and a 'bitter almond' odor in a metal plating worker is pathognomonic for acute cyanide poisoning. Cyanide induces cellular injury by acting as a chemical asphyxiant. It rapidly crosses cell membranes and binds with high affinity to the ferric iron (Fe3+) within cytochrome c oxidase (Complex IV) of the mitochondrial electron transport chain. This binding completely blocks the transfer of electrons to oxygen, halting oxidative phosphorylation and ATP production. Consequently, cells are forced into anaerobic metabolism, generating massive amounts of lactate. Because tissues cannot extract oxygen from the blood, venous blood remains highly oxygenated, which clinically manifests as flushed skin.

Step-by-Step Solution

1
Analyze the clinical presentation and occupational history.
The patient is a metal plating worker presenting with sudden collapse, flushed skin, and a bitter almond odor, which strongly suggests acute chemical intoxication.
Metal plating is a high-risk occupation for cyanide exposure, and the bitter almond odor is a classic (though inconsistently detected) finding.
2
Interpret the laboratory findings.
The ABG shows severe high anion gap metabolic acidosis with a normal pO2 and markedly elevated lactate.
This profile indicates profound tissue hypoxia and reliance on anaerobic metabolism despite adequate oxygen delivery to the blood, pointing to chemical asphyxiation.
3
Identify the underlying toxicologic cellular mechanism.
Cyanide binds to the ferric iron (Fe3+) in cytochrome c oxidase (Complex IV) of the mitochondrial electron transport chain.
This interaction halts oxidative phosphorylation, preventing oxygen utilization and leading to rapid ATP depletion, cellular asphyxiation, and lactic acidosis.

Key Concept

Cyanide induces severe cellular injury by binding to the ferric iron (Fe3+) in cytochrome c oxidase (Complex IV), completely halting aerobic metabolism and ATP production.
Estimated Time:2m 0s
Question 102Question →

A 6262-year-old woman is evaluated in the oncology clinic for progressive shortness of breath and right upper quadrant abdominal fullness over the past three weeks. She has a history of metastatic non-small cell lung cancer (NSCLC) diagnosed 2020 months ago. At the time of initial diagnosis, molecular testing of the lung primary tumor revealed an epidermal growth factor receptor (EGFR) exon 1919 deletion. She was started on osimertinib, with a robust partial response. She has no other significant past medical history and has never smoked. Current vital signs are within normal limits.

Physical examination reveals decreased breath sounds at the right lung base and a palpable, slightly tender liver edge 44 cm below the right costal margin. Restaging computed tomography (CT) of the chest, abdomen, and pelvis demonstrates enlargement of the primary right lung mass, new right-sided pleural effusion, and multiple new, hypervascular hepatic lesions.

A liquid biopsy (cell-free DNA) is performed and confirms the presence of the original EGFR exon 1919 deletion but is negative for secondary EGFR mutations, including T790M and C797S, as well as MET amplification. Subsequently, an ultrasound-guided core needle biopsy of one of the new hepatic lesions is performed. Histopathologic evaluation of the liver specimen reveals sheets of small cells with scant cytoplasm, finely granular nuclear chromatin, and absent glandular architecture. Immunohistochemical staining is strongly positive for synaptophysin and chromogranin A.

Based on the patient's new clinicopathologic findings, which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate combination therapy with etoposide and a platinum agent

Answer

Initiate combination therapy with etoposide and a platinum agent
The correct answer is to initiate combination therapy with etoposide and a platinum agent. This patient with EGFR-mutated lung adenocarcinoma has developed acquired resistance to the third-generation EGFR inhibitor, osimertinib. While acquired secondary kinase domain mutations (such as C797S) and bypass track signaling (such as MET amplification) are common resistance mechanisms, approximately 3%3\% to 15%15\% of EGFR-mutated NSCLCs undergo lineage plasticity and transform into small cell lung cancer (SCLC). The recent liver biopsy exhibits classic SCLC histology: solid sheets of cells with scant cytoplasm, finely granular chromatin, absent glandular architecture, and positive staining for neuroendocrine markers (synaptophysin, chromogranin A). The original EGFR mutation is typically retained, as seen in this patient's cell-free DNA. Once histologic transformation to SCLC is confirmed, the tumor behaves clinically like primary SCLC. Therefore, standard-of-care management must pivot to an SCLC-directed cytotoxic chemotherapy regimen, typically a platinum agent combined with etoposide.

Step-by-Step Solution

1
Analyze the patient's initial diagnosis and current therapy.
The patient has EGFR-mutated NSCLC and has been receiving osimertinib for 2020 months.
Establishing the baseline molecular profile is essential to understanding potential acquired resistance mechanisms.
2
Interpret the new biopsy findings from the progressing hepatic lesion.
The biopsy shows sheets of small cells, granular chromatin, and positivity for synaptophysin and chromogranin A, confirming neuroendocrine differentiation.
Identifying the precise histologic changes explains the clinical progression despite ongoing targeted therapy.
3
Synthesize the clinical history and pathology to determine the resistance mechanism.
The findings indicate histologic transformation from adenocarcinoma to small cell lung cancer (SCLC).
Accurate characterization of the tumor's new biology dictates the subsequent treatment strategy.
4
Determine the standard of care management for the newly identified tumor histology.
The appropriate treatment for extensive-stage SCLC is cytotoxic chemotherapy with a platinum agent and etoposide.
The tumor is no longer solely dependent on the EGFR pathway; therefore, EGFR inhibitors are insufficient, and SCLC requires aggressive chemotherapy.

Key Concept

Histologic transformation to small cell lung cancer (SCLC) is a known mechanism of acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC, presenting with neuroendocrine morphology and requiring a shift to SCLC-directed chemotherapy.
Question 103Question →

A 42-year-old woman is brought to the emergency department by her husband due to progressive confusion, unsteadiness, and hand tremors over the past 3 days. She has a history of bipolar disorder and has been stable on a fixed dose of lithium carbonate for the last three years. Two weeks ago, she was diagnosed with osteoarthritis of the knee and began taking a newly prescribed daily oral medication for joint pain. Her vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 138/85 mmHg138/85\text{ mmHg}, pulse 88/min88/\text{min}, and respiratory rate 14/min14/\text{min}. Physical examination reveals a coarse resting tremor and marked ataxia. Laboratory studies show a serum lithium concentration of 2.1 mEq/L2.1\text{ mEq/L} (therapeutic range: 0.6−1.2 mEq/L0.6-1.2\text{ mEq/L}) and a serum creatinine of 1.4 mg/dL1.4\text{ mg/dL} (baseline: 0.8 mg/dL0.8\text{ mg/dL}). The newly prescribed medication is identified as the likely cause of her current condition. Which of the following pharmacokinetic mechanisms best explains this patient's acute toxicity?

Show answer & explanation

Answer: Reduced glomerular filtration and enhanced proximal tubular reabsorption

Answer

Reduced glomerular filtration and enhanced proximal tubular reabsorption
The correct answer accurately links the physiologic effect of NSAIDs to the pharmacokinetic handling of lithium. The patient's elevated creatinine and lithium levels point to a renal interaction. NSAIDs inhibit the synthesis of vasodilatory prostaglandins, leading to vasoconstriction of the afferent arteriole. This reduces the glomerular filtration rate (GFR). In response to a lower GFR, the kidneys attempt to preserve volume by upregulating the reabsorption of sodium in the proximal tubule. Because the proximal tubule cannot distinguish well between sodium and lithium, lithium is reabsorbed alongside sodium, resulting in decreased lithium clearance and acute systemic toxicity.

Step-by-Step Solution

1
Identify the clinical syndrome and the likely offending agent.
The patient has acute lithium toxicity (tremor, ataxia, confusion, level of 2.1 mEq/L) triggered by a new medication for osteoarthritis, which is almost certainly a nonsteroidal anti-inflammatory drug (NSAID).
Connecting the new symptom onset with the osteoarthritis treatment establishes the drug-drug interaction context.
2
Determine the pharmacological effect of NSAIDs on renal physiology.
NSAIDs inhibit cyclooxygenase, decreasing prostaglandin production. Since prostaglandins normally dilate the afferent arteriole, their absence leads to afferent vasoconstriction and a decreased glomerular filtration rate (GFR).
Understanding the foundational mechanism of NSAID-induced nephrotoxicity is required to trace the pharmacokinetic impact.
3
Apply the altered renal physiology to the pharmacokinetics of lithium.
A decreased GFR triggers the kidneys to compensate by increasing sodium reabsorption in the proximal tubule. Because lithium is handled identically to sodium in this nephron segment, its reabsorption also increases, drastically reducing its clearance and causing toxic accumulation.
This confirms that reduced clearance via enhanced proximal reabsorption is the precise pharmacokinetic mechanism of the interaction.

Key Concept

NSAIDs cause lithium toxicity by inhibiting renal prostaglandin synthesis, which decreases afferent arteriolar blood flow and GFR, leading to a compensatory increase in the proximal tubular reabsorption of both sodium and lithium.
Estimated Time:1m 30s
Question 104Question →

A 45-year-old man with type 1 diabetes mellitus is brought to the emergency department after being found unresponsive by his wife. His capillary blood glucose is 32 mg/dL. He is administered intramuscular glucagon, which promptly restores his consciousness and raises his blood glucose levels by promoting hepatic glycogenolysis. Arrange the following steps of the intracellular signal transduction cascade in the correct chronological order, starting immediately after the medication reaches the hepatocyte.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Receptor binding -> Gs subunit activation -> cAMP generation -> PKA activation -> Target enzyme phosphorylation.
The sequence correctly traces the Gs-protein coupled receptor (GPCR) pathway utilized by glucagon. The process begins with the ligand binding the receptor on the cell surface. This induces a conformational change that activates the Gs protein, causing its alpha subunit to stimulate adenylyl cyclase. Adenylyl cyclase then converts ATP into cAMP. Increased levels of intracellular cAMP subsequently activate protein kinase A (PKA). Finally, PKA phosphorylates specific target enzymes, such as activating glycogen phosphorylase kinase and inactivating glycogen synthase, thereby promoting the rapid breakdown of glycogen and the release of glucose into the blood.

Step-by-Step Solution

1
Identify the receptor type for glucagon.
Glucagon acts on a Gs protein-coupled receptor (GPCR).
Understanding the receptor class is required to deduce the intracellular signaling pathway.
2
Trace the activation sequence of a Gs protein.
Ligand binding causes the Gs-alpha subunit to dissociate and activate adenylyl cyclase.
This is the direct membrane-bound consequence of GPCR activation.
3
Identify the secondary messenger produced by the effector enzyme.
Adenylyl cyclase converts ATP into cAMP.
cAMP acts as the intracellular amplifier for the hormone signal.
4
Determine the direct target of the secondary messenger.
cAMP binds to and activates Protein Kinase A (PKA).
PKA is the primary effector for cAMP-mediated cellular responses in this pathway.
5
Identify the final functional outcome of the cascade.
PKA phosphorylates downstream metabolic enzymes.
Phosphorylation activates glycogen phosphorylase kinase, directly leading to glycogenolysis.

Key Concept

Glucagon acts via a Gs protein-coupled receptor to increase cAMP, activate PKA, and phosphorylate metabolic enzymes to rapidly induce glycogenolysis.
Estimated Time:45s
Question 105Question →

A 68-year-old man is hospitalized for management of infective endocarditis involving a prosthetic aortic valve. Blood cultures drawn on admission grow methicillin-resistant *Staphylococcus aureus* (MRSA). He is started on intravenous vancomycin, and subsequent trough levels are maintained consistently between 1515 and 20μg/mL20 \mu\text{g/mL}. The patient's clinical status improves, and repeat blood cultures on day 44 are sterile. However, on day 1818 of hospitalization, he develops a new fever of 38.9∘C38.9^\circ\text{C} (102.0∘F102.0^\circ\text{F}) and worsening fatigue. Repeat blood cultures again grow MRSA. Susceptibility testing of the new bacterial isolate reveals a vancomycin minimum inhibitory concentration (MIC) of 4μg/mL4 \mu\text{g/mL}, compared to an initial MIC of 1μg/mL1 \mu\text{g/mL}. Which of the following best describes the molecular mechanism responsible for this pathogen's reduced susceptibility to the current therapy?

Show answer & explanation

Answer: Synthesis of an abnormally thick peptidoglycan wall containing excessive target binding sites

Answer

Synthesis of an abnormally thick peptidoglycan wall containing excessive target binding sites
The correct answer identifies the mechanism for Vancomycin-Intermediate Staphylococcus aureus (VISA). VISA typically emerges in patients receiving prolonged vancomycin therapy (such as for endocarditis or osteomyelitis) and is characterized by a gradual increase in the minimum inhibitory concentration (MIC), known as 'MIC creep.' An MIC of 44 to 8μg/mL8 \mu\text{g/mL} defines VISA. The underlying pathophysiology involves spontaneous point mutations that alter cell wall metabolism, leading to the synthesis of an exceptionally thick peptidoglycan layer. This hyper-thickened wall contains a vast excess of D-alanyl-D-alanine terminal residues. These residues act as 'decoys' or a sponge, binding vancomycin molecules in the outer layers of the cell wall. Consequently, the drug becomes physically trapped and cannot penetrate deeply enough to reach the critically located cell membrane precursors where it normally exerts its inhibitory effect on cross-linking.

Step-by-Step Solution

1
Analyze the clinical scenario and the change in microbiological data.
A patient with MRSA endocarditis initially responding to vancomycin develops recurrent bacteremia. The MRSA isolate's vancomycin MIC has increased from 1μg/mL1 \mu\text{g/mL} to 4μg/mL4 \mu\text{g/mL}.
Identifying the shift in the MIC is crucial for diagnosing the specific type of antimicrobial resistance that has emerged during therapy.
2
Interpret the new vancomycin MIC value.
An MIC of 4μg/mL4 \mu\text{g/mL} for Staphylococcus aureus indicates Vancomycin-Intermediate S. aureus (VISA). (Susceptible is <= 2μg/mL2 \mu\text{g/mL}, Intermediate is 4−8μg/mL4-8 \mu\text{g/mL}, Resistant is >= 16μg/mL16 \mu\text{g/mL}).
Differentiating between intermediate and high-level resistance dictates the specific molecular mechanism involved.
3
Determine the molecular mechanism underlying VISA.
VISA emerges through stepwise chromosomal mutations that result in a markedly thickened peptidoglycan cell wall.
This thick wall contains abundant D-alanyl-D-alanine residues that act as false targets, trapping vancomycin in the outer cell wall and preventing it from reaching the critically located targets at the cytoplasmic membrane.

Key Concept

Vancomycin-Intermediate Staphylococcus aureus (VISA) resistance mechanism
Estimated Time:1m 30s
Question 106Question →

Match each clinical presentation described below with its primary underlying genetic or molecular pathophysiologic mechanism.

Click a left item, then click its matching right item

Items

A 9-year-old girl with severe facial freckling and multiple basal cell carcinomas on sun-exposed skin areas.
A 42-year-old man with progressive choreiform movements, behavioral changes, and caudate nucleus atrophy.
A 7-year-old boy with progressive cerebellar ataxia, recurrent sinopulmonary infections, and conjunctival vascular lesions.
A 24-year-old man with tall stature, ectopia lentis, and echocardiographic evidence of aortic root dilation.

Matches

Show answer & explanation

Answer

The presentations map to their respective molecular defects: Xeroderma pigmentosum corresponds to defective nucleotide excision repair; Huntington disease to toxic gain-of-function from trinucleotide expansion; Ataxia-telangiectasia to impaired nonhomologous end joining; and Marfan syndrome to mutant glycoprotein causing excessive TGF-beta signaling.
Each clinical vignette maps directly to a unique molecular pathway defect. Xeroderma pigmentosum results from a failure to repair UV-induced pyrimidine dimers via nucleotide excision repair. Huntington disease is caused by CAG trinucleotide repeat expansion, leading to a toxic gain-of-function huntingtin protein. Ataxia-telangiectasia is due to ATM gene mutations, disrupting the nonhomologous end joining repair of double-strand DNA breaks. Marfan syndrome is caused by FBN1 mutations, producing abnormal fibrillin-1 that fails to regulate TGF-beta signaling appropriately.

Step-by-Step Solution

1
Identify the clinical syndrome described in each vignette on the left.
The vignettes represent Xeroderma pigmentosum, Huntington disease, Ataxia-telangiectasia, and Marfan syndrome, respectively.
Accurate clinical diagnosis is the required first step before mapping the phenotype to a molecular defect.
2
Determine the specific genetic or molecular abnormality underlying each identified condition.
Xeroderma pigmentosum involves nucleotide excision repair; Huntington disease involves a polyglutamine tract causing protein misfolding; Ataxia-telangiectasia involves the ATM gene and nonhomologous end joining; Marfan syndrome involves fibrillin-1 and TGF-beta dysregulation.
Matching the clinical syndrome to its fundamental pathophysiology tests the core genetic mechanisms.

Key Concept

Understanding the precise molecular and genetic mechanisms underlying distinct clinical phenotypes is essential for accurate diagnosis and management of inherited disorders.
Question 107Question →

A 55-year-old man with a history of alcohol use disorder and compensated cirrhosis presents to the clinic to discuss an upcoming umbilical hernia repair. He reports no recent bleeding episodes, and a recent screening endoscopy showed small esophageal varices without stigmata of recent bleeding. Vital signs are within normal limits. Laboratory evaluation reveals:

* Hemoglobin: 12.4 g/dL12.4 \text{ g/dL}
* Platelets: 85,000/μL85,000/\mu L
* Prothrombin time (PT): 18 seconds18 \text{ seconds} (Reference: 11−14 seconds11-14 \text{ seconds})
* INR: 1.71.7
* Activated partial thromboplastin time (aPTT): 34 seconds34 \text{ seconds} (Reference: 25−40 seconds25-40 \text{ seconds})

The surgeon expresses concern regarding the prolonged INR and requests a hematology consultation for preoperative optimization. The hematologist recommends proceeding with the surgery without the prophylactic administration of fresh frozen plasma. Which of the following principles of hemodynamics and coagulation best justifies this recommendation?

Show answer & explanation

Answer: Commensurate decline in the production of endogenous anticoagulant proteins preserves the overall hemostatic balance.

Answer

Commensurate decline in the production of endogenous anticoagulant proteins preserves the overall hemostatic balance.
The correct answer identifies that patients with advanced liver disease develop a 'rebalanced hemostatic state.' The liver is responsible for synthesizing most procoagulant factors (e.g., Factors II, VII, IX, X), and their decline leads to a prolonged PT and INR. However, the liver also synthesizes critical endogenous anticoagulant proteins, specifically Protein C, Protein S, and Antithrombin. Because the production of these anticoagulants declines commensurately with the procoagulants, the overall hemostatic balance is often maintained. Therefore, a prolonged INR in a patient with cirrhosis does not reliably predict surgical bleeding risk, and the prophylactic administration of fresh frozen plasma is generally not recommended solely to correct the laboratory number.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and laboratory findings.
The patient has established cirrhosis with expected thrombocytopenia and an elevated INR, but no clinical signs of abnormal bleeding.
To identify the baseline hemostatic status prior to an invasive surgical procedure.
2
Evaluate the specialist's recommendation to withhold prophylactic fresh frozen plasma (FFP).
The hematologist recognizes that an elevated INR in the setting of cirrhosis does not equate to a true bleeding diathesis.
Traditional coagulation tests (PT/INR) only measure procoagulant pathways and fail to capture the entire hemostatic picture in liver disease.
3
Identify the fundamental mechanism of hemostasis in patients with cirrhosis.
Cirrhosis causes a parallel, commensurate decrease in both liver-derived procoagulant factors (II, VII, IX, X, V, XI) and endogenous anticoagulant proteins (Protein C, Protein S, Antithrombin).
This physiological adaptation creates a 'rebalanced' hemostatic state, explaining why patients with cirrhosis can maintain adequate hemostasis during surgery despite abnormal traditional laboratory values.

Key Concept

Patients with cirrhosis exist in a 'rebalanced hemostatic state' due to a simultaneous decline in the hepatic synthesis of both procoagulant factors and endogenous anticoagulant proteins.
Estimated Time:2m 0s
Question 108Question →

A 38-year-old woman is admitted to the intensive care unit with profound hypotension, widespread purpuric skin lesions, and persistent oozing from her intravenous catheter sites following an emergency dilation and curettage for a septic abortion. Laboratory studies reveal a platelet count of 22,000/mm322,000/\text{mm}^3, a significantly prolonged prothrombin time, a decreased fibrinogen level, and a markedly elevated D-dimer. Arrange the pathophysiologic events underlying this patient's hematologic and hemodynamic collapse in the correct chronological sequence, from the initial trigger to the final clinical manifestation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct pathophysiologic sequence begins with the inflammatory upregulation of tissue factor, which triggers the extrinsic pathway leading to systemic thrombin generation. This causes widespread microvascular fibrin deposition, subsequently leading to the consumptive depletion of platelets and coagulation factors, and finally concluding with the secondary plasmin-mediated fibrinolysis that produces D-dimers and worsens the severe bleeding.
Disseminated intravascular coagulation (DIC) is characterized by an initial systemic procoagulant phase followed by a consumptive hemorrhagic phase. The sequence strictly begins with an inciting trigger (endothelial injury and tissue factor release), leading to uninhibited thrombin generation. Thrombin drives the formation of fibrin microthrombi (causing ischemia). The extensive creation of these clots consumes the available pool of platelets and coagulation factors. Finally, the body's endogenous fibrinolytic system (plasmin) breaks down these clots, elevating D-dimer levels and contributing to the bleeding diathesis via the inhibitory effects of fibrin degradation products.

Step-by-Step Solution

1
Identify the inciting event triggering the coagulation cascade.
Systemic inflammation (sepsis) causes endothelial damage and upregulates tissue factor.
Sepsis induces a cytokine storm that alters the normally antithrombotic endothelial surface to a prothrombotic state by exposing tissue factor to the bloodstream.
2
Determine the immediate biochemical consequence of tissue factor exposure.
Activation of the extrinsic pathway and massive thrombin generation.
Tissue factor is the primary physiologic initiator of coagulation; its widespread exposure leads to uncontrolled thrombin production.
3
Trace the direct effect of unregulated thrombin in the circulation.
Conversion of fibrinogen to fibrin, resulting in microvascular thrombosis.
Thrombin acts on fibrinogen to form fibrin meshes, which lodge in small vessels, leading to ischemia and red blood cell shearing (schistocytes).
4
Identify the mechanism behind the onset of the bleeding diathesis.
Profound consumption of platelets and coagulation factors.
Because the coagulation cascade is continuously activated systemically, the body's stores of platelets and soluble clotting factors are rapidly depleted.
5
Determine the counter-regulatory response and its clinical effect.
Secondary fibrinolysis generates fibrin degradation products (FDPs) like D-dimer.
Plasmin attempts to clear the widespread clots but generates FDPs, which interfere with further fibrin polymerization and platelet function, worsening the hemorrhage.

Key Concept

Pathophysiology and temporal sequence of Disseminated Intravascular Coagulation (DIC)
Question 109Question →

A 7474-year-old man with a history of nonvalvular atrial fibrillation and hypertension is admitted to the hospital with hemoptysis and a cavitary lung lesion. He is diagnosed with chronic pulmonary histoplasmosis. The infectious disease consultant recommends initiating therapy with oral itraconazole.

The patient's outpatient medications include rivaroxaban 20 mg20 \text{ mg} once daily and amlodipine 5 mg5 \text{ mg} once daily.

His baseline laboratory studies on admission show:
- Hemoglobin: 13.8 g/dL13.8 \text{ g/dL}
- Serum creatinine: 1.2 mg/dL1.2 \text{ mg/dL} (Estimated creatinine clearance: 58 mL/min58 \text{ mL/min})

Four days after starting itraconazole, the patient develops acute-onset hematemesis and melena. He becomes hypotensive and tachycardic. Repeat laboratory studies show:
- Hemoglobin: 7.4 g/dL7.4 \text{ g/dL}
- Serum creatinine: 1.4 mg/dL1.4 \text{ mg/dL}

Which of the following best describes the primary mechanism responsible for this patient's acute gastrointestinal hemorrhage?

Show answer & explanation

Answer: Inhibition of both cytochrome P450-mediated hepatic metabolism and P-glycoprotein-mediated active efflux

Answer

The hemorrhage is caused by the inhibition of both cytochrome P450-mediated hepatic metabolism and P-glycoprotein-mediated active efflux.
The correct answer identifies the severe pharmacokinetic drug-drug interaction between direct oral anticoagulants (DOACs) and azole antifungals. Rivaroxaban's disposition depends on both cytochrome P450 3A4 (CYP3A4) for hepatic metabolism and P-glycoprotein (P-gp) for intestinal and renal efflux. Itraconazole is a potent inhibitor of both pathways. When coadministered, itraconazole prevents the metabolism and efflux of rivaroxaban, leading to a profound increase in the area under the curve (AUC) and peak plasma concentrations. This toxic accumulation directly resulted in the patient's acute, life-threatening gastrointestinal hemorrhage.

Step-by-Step Solution

1
Identify the primary active medications involved in the clinical change.
The patient is taking rivaroxaban (a direct oral anticoagulant) and was recently started on itraconazole (an azole antifungal).
Recognizing newly added medications is critical for identifying potential drug-drug interactions that precipitate acute clinical deterioration.
2
Analyze the pharmacokinetic properties of the anticoagulant.
Rivaroxaban is metabolized hepatically by CYP3A4 and is also a substrate for the P-glycoprotein (P-gp) efflux transporter in the gut and kidneys.
Understanding the clearance pathways of direct oral anticoagulants is necessary to predict how other drugs might alter their systemic levels.
3
Determine the pharmacokinetic effect of the newly added medication.
Itraconazole is a potent inhibitor of both CYP3A4 and P-gp.
Azole antifungals, macrolide antibiotics, and protease inhibitors are classic dual inhibitors of these specific metabolic and transport pathways.
4
Synthesize the interaction to explain the patient's presentation.
The dual inhibition drastically reduces rivaroxaban clearance and increases its bioavailability, leading to supratherapeutic plasma levels and severe gastrointestinal hemorrhage.
Connecting the pharmacokinetic mechanism directly to the adverse clinical outcome confirms the diagnosis.

Key Concept

Direct oral anticoagulants like rivaroxaban and apixaban rely heavily on CYP3A4 and P-glycoprotein for clearance; concomitant administration of potent dual inhibitors (e.g., itraconazole, ritonavir) leads to dangerous drug accumulation and severe bleeding.
Estimated Time:1m 30s
Question 110Question →

Review the following clinical presentations and histopathological findings. Match each patient scenario to the precise underlying subcellular mechanism or biochemical hallmark responsible for the described cellular adaptation or injury.

Click a left item, then click its matching right item

Items

A 58-year-old man with an anterior myocardial infarction undergoes successful percutaneous coronary intervention. Three hours post-procedure, he experiences transient ventricular arrhythmias, and his cardiac biomarkers peak significantly earlier than expected.
A 64-year-old woman treated with paclitaxel for ovarian carcinoma develops severe oral mucositis. Mucosal biopsy reveals individual epithelial cells exhibiting profound cytoplasmic shrinkage and marked chromatin condensation, lacking a surrounding neutrophilic infiltrate.
A 12-year-old boy presents with progressive night blindness and thickened, dry conjunctivae containing small, opaque, foamy plaques. Conjunctival scraping shows keratinized squamous epithelium replacing the normal stratified columnar epithelium.
A 45-year-old woman with a history of infective endocarditis develops sudden-onset left upper quadrant abdominal pain. Computed tomography shows a wedge-shaped splenic defect. Biopsy of the affected area demonstrates preserved cellular architecture with an intensely eosinophilic cytoplasm and completely absent nuclei.

Matches

Show answer & explanation

Answer

The clinical vignettes correlate with ischemia-reperfusion injury (ROS generation), intrinsic apoptosis (cytochrome c release), metaplasia (stem cell reprogramming), and coagulative necrosis (protein denaturation), respectively.
Each clinical scenario precisely matches a distinct cellular injury or adaptation mechanism. Reperfusion injury is driven by free radical generation; chemotherapy-induced apoptosis is mediated by mitochondrial cytochrome c; metaplasia stems from transcriptional reprogramming of basal cells; and coagulative necrosis is characterized by the denaturation of intracellular proteins due to severe acidosis.

Step-by-Step Solution

1
Analyze the first vignette describing early biomarker peaking and arrhythmias post-stenting.
Identify this as ischemia-reperfusion injury.
Re-establishing blood flow paradoxically exacerbates cellular damage via reactive oxygen species and mitochondrial permeability transition pore opening.
2
Analyze the second vignette describing single-cell death with chromatin condensation and no inflammation after chemotherapy.
Identify this as intrinsic apoptosis.
Chemotherapy induces DNA damage, which triggers mitochondrial cytochrome c release and caspase activation.
3
Analyze the third vignette describing squamous epithelium replacing columnar epithelium in a patient with night blindness.
Identify this as squamous metaplasia secondary to Vitamin A deficiency.
Vitamin A is required for maintaining specialized epithelia; its absence causes stem cell reprogramming toward a keratinized squamous phenotype.
4
Analyze the fourth vignette describing a wedge-shaped splenic infarct with preserved cellular outlines.
Identify this as coagulative necrosis.
Ischemic cell death in most solid organs results in intracellular acidosis that denatures proteins and enzymes, temporarily preserving the structural architecture.

Key Concept

Cellular adaptation and injury mechanisms are defined by specific biochemical and subcellular alterations, ranging from stem cell reprogramming in metaplasia to precise proteolytic cascades in apoptosis and structural protein denaturation in coagulative necrosis.
Question 111Question →

A hematology consultation service is evaluating four patients with undiagnosed bleeding diatheses and suspected hereditary coagulopathies. Pair each patient's clinical presentation and initial laboratory screening with the specific confirmatory diagnostic finding that best establishes the underlying defect.

Click a left item, then click its matching right item

Items

A 24-year-old female with lifelong mucocutaneous bleeding and normal prothrombin time (PT) and activated partial thromboplastin time (aPTT); initial aggregometry shows no response to ADP or epinephrine.
A 4-year-old boy with a history of delayed umbilical stump separation presenting with spontaneous intramuscular hematomas; PT, aPTT, fibrinogen, and platelet counts are entirely normal.
A 32-year-old female with recurrent first-trimester pregnancy losses and a family history of mixed bleeding and thrombotic events; PT and aPTT are normal, but thrombin time is markedly prolonged.
A 17-year-old male with a history of severe epistaxis, mild thrombocytopenia, and large platelets on peripheral smear; PT and aPTT are within reference ranges.

Matches

Show answer & explanation

Answer

The presentations map to classic laboratory findings for Glanzmann thrombasthenia, Factor XIII deficiency, Dysfibrinogenemia, and Bernard-Soulier syndrome.
Each clinical presentation describes a classic hereditary bleeding or coagulation disorder that requires specialized laboratory testing beyond standard PT/aPTT panels. By correlating the cellular or molecular defect with its distinct in vitro behavior, the correct pathophysiology is matched precisely to the diagnostic assay.

Step-by-Step Solution

1
Analyze the 24-year-old female with absent response to ADP/epinephrine.
Identified as Glanzmann thrombasthenia, which uniquely shows normal ristocetin agglutination.
Deficiency of GPIIb/IIIa impairs aggregation to standard agonists but preserves ristocetin-induced agglutination via the intact GPIb receptor.
2
Evaluate the 4-year-old boy with delayed umbilical stump bleeding and normal standard coagulation times.
Identified as Factor XIII deficiency, confirmed by clot dissolution in 5M urea.
Factor XIII stabilizes fibrin but its activity is not captured by PT/aPTT assays; the clot solubility test is the definitive diagnostic step.
3
Assess the 32-year-old female with prolonged thrombin time, pregnancy loss, and normal PT/aPTT.
Identified as dysfibrinogenemia, characterized by discordant functional/antigenic levels and prolonged reptilase time.
Structurally abnormal fibrinogen prolongs TT and reptilase time while demonstrating a mismatch between quantity (antigenic) and quality (functional).
4
Analyze the 17-year-old male with macrothrombocytopenia and epistaxis.
Identified as Bernard-Soulier syndrome, defined by absent ristocetin response that does not correct with plasma.
The absence of the GPIb receptor prevents ristocetin-induced agglutination, and because the defect is cellular rather than humoral, donor plasma cannot correct it.

Key Concept

Diagnostic laboratory evaluation of specialized coagulation factor defects and hereditary platelet function disorders
Question 112Question →

A 32-year-old man presents to the physical therapy clinic for his initial evaluation following a right knee anterior cruciate ligament (ACL) reconstruction. For the past four weeks, his right lower extremity has been immobilized in a rigid extension brace, and he has been strictly non-weight-bearing. On physical examination, the surgical incisions are well-healed without erythema or discharge. However, the circumference of his right mid-thigh is 4.5 cm less than that of his left mid-thigh. He reports no pain or paresthesias in the limb. Which of the following intracellular processes is primarily responsible for the macroscopic changes observed in this patient's right lower extremity?

Show answer & explanation

Answer: Covalent attachment of ubiquitin to cytoskeletal proteins

Answer

The correct answer is the covalent attachment of ubiquitin to cytoskeletal proteins, which facilitates targeted protein degradation.
The patient's clinical presentation of muscle wasting after prolonged casting is a classic example of disuse atrophy. At the cellular level, atrophy is characterized by a reduction in the size of the cell to achieve a new equilibrium with a reduced workload or nutrient supply. This shrinkage is achieved through decreased protein synthesis and increased protein degradation. The primary mechanism for degrading intracellular proteins in this context is the ubiquitin-proteasome pathway. Nutrient deficiency or disuse activates ubiquitin ligases, which attach ubiquitin molecules to target cytoskeletal proteins. These 'tagged' proteins are then recognized and degraded by the proteasome.

Step-by-Step Solution

1
Analyze the clinical presentation and physical exam findings.
The patient has a 4.5 cm reduction in thigh circumference after four weeks of immobilization, indicating profound muscle wasting.
Establishing the clinical diagnosis of disuse atrophy is the first step before determining the subcellular mechanism.
2
Determine the cellular adaptation taking place.
The skeletal muscle cells have undergone atrophy (shrinkage in cell size), rather than necrosis or apoptosis.
Matching the clinical sign (muscle wasting without inflammation or cell death) to the correct adaptive response narrows down the potential molecular pathways.
3
Identify the primary molecular mechanism of cellular atrophy.
Atrophy occurs via decreased protein synthesis and increased protein degradation, primarily driven by the ubiquitin-proteasome pathway.
This directly answers the stem's question regarding the intracellular process responsible for the macroscopic changes.

Key Concept

Disuse atrophy of skeletal muscle is a reversible cellular adaptation characterized by decreased cell size, primarily mediated by increased degradation of cytoskeletal proteins via the ubiquitin-proteasome pathway.
Question 113Question →

A 58-year-old man is brought to the emergency department due to a persistent nosebleed that began 3 hours ago. He has a history of type 2 diabetes mellitus, hypertension, and end-stage renal disease. The patient reports missing his last three hemodialysis sessions due to a lack of transportation. His blood pressure is 168/92 mmHg, and his heart rate is 94/min. Physical examination shows continuous oozing of blood from both nares despite the application of direct pressure and anterior nasal packing. Laboratory studies reveal the following:

Hemoglobin: 9.2 g/dL
Platelet count: 210,000/mm³
Blood urea nitrogen: 96 mg/dL
Serum creatinine: 7.8 mg/dL
Prothrombin time: 11 seconds
Partial thromboplastin time: 26 seconds

Which of the following best describes the mechanism of action of the most appropriate initial pharmacologic therapy for this patient's bleeding?

Show answer & explanation

Answer: Stimulation of endothelial cells to release stored von Willebrand factor

Answer

The most appropriate initial pharmacologic therapy is desmopressin (DDAVP), which works by stimulating endothelial cells to release stored von Willebrand factor.
The patient is experiencing acute mucosal bleeding due to uremic platelet dysfunction, a consequence of his missed hemodialysis sessions leading to the accumulation of uremic toxins. These toxins interfere with platelet-platelet and platelet-endothelium interactions, specifically impairing von Willebrand factor (vWF) binding and glycoprotein IIb/IIIa function. This results in defective primary hemostasis characterized by a prolonged bleeding time, but a normal platelet count, prothrombin time (PT), and partial thromboplastin time (PTT). The most appropriate initial pharmacologic therapy is desmopressin (DDAVP). DDAVP is a synthetic analogue of vasopressin that stimulates the release of vWF and factor VIII from the Weibel-Palade bodies of endothelial cells. The sudden increase in circulating high-molecular-weight vWF multimers enhances platelet adhesion to the damaged endothelium, effectively arresting the bleeding. While resuming hemodialysis is the definitive treatment to clear the uremic toxins, DDAVP is utilized for rapid, short-term hemostatic control.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and laboratory results.
The patient has mucosal bleeding (epistaxis), elevated BUN and creatinine due to missed dialysis, a normal platelet count, and normal coagulation studies (PT, PTT).
To accurately diagnose the underlying cause of the bleeding.
2
Identify the primary pathophysiologic defect based on the clinical findings.
The findings indicate uremic platelet dysfunction, a qualitative platelet defect caused by the accumulation of uremic toxins (e.g., guanidinosuccinic acid) that impair platelet adhesion and aggregation.
Understanding the precise defect is essential for selecting targeted, effective therapy.
3
Determine the most appropriate initial pharmacologic intervention and its cellular mechanism.
Desmopressin (DDAVP) is the appropriate initial pharmacotherapy. It acts by inducing the exocytosis of von Willebrand factor and factor VIII from endothelial Weibel-Palade bodies, temporarily correcting the adhesion defect.
While resuming hemodialysis is the definitive treatment to clear the toxins, DDAVP provides rapid, short-term hemostasis in acute bleeding scenarios.

Key Concept

Uremic platelet dysfunction causes abnormal primary hemostasis despite a normal platelet count and normal coagulation studies. Desmopressin (DDAVP) is the initial pharmacotherapy of choice, acting by releasing stored von Willebrand factor from endothelial cells to facilitate platelet adhesion.
Question 114Question →

A 24-year-old medical resident presents to the occupational health clinic in late January with sudden-onset high fever, severe myalgias, dry cough, and profound fatigue. She notes several of her patients had similar symptoms over the past week. A rapid point-of-care test confirms infection with an enveloped, negative-sense, single-stranded RNA virus with a segmented genome. The pathogen relies on a specific sequence of molecular events to successfully invade respiratory epithelial cells. Arrange the following steps of this virus's early entry and uncoating mechanism in the correct chronological order, from initial host cell contact to the delivery of its genetic material for replication.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for influenza virus entry is: 1) Viral surface glycoprotein binds to host cell sialic acid residues. 2) Invagination of the host cell membrane and formation of a virus-containing endosome. 3) Influx of protons into the virion interior via viral M2 ion channels. 4) Conformational change of the viral surface glycoprotein triggering envelope-endosome membrane fusion. 5) Translocation of viral ribonucleoproteins from the cytoplasm into the host nucleus.
Influenza infection begins when viral Hemagglutinin (HA) binds to sialic acid on the respiratory epithelium. This triggers receptor-mediated endocytosis. Inside the host cell, the endosome undergoes natural acidification. The low pH environment activates the viral M2 ion channel, which pumps protons into the virion to dissociate the viral matrix. Simultaneously, the acidic pH causes a conformational change in HA, mediating fusion between the viral envelope and the endosomal membrane. Finally, the uncoated viral ribonucleoproteins are released into the cytoplasm and translocated into the nucleus, a unique step for orthomyxoviruses, allowing replication to begin.

Step-by-Step Solution

1
Identify the specific pathogen described in the vignette.
The patient has influenza, caused by the influenza virus (an enveloped, negative-sense, segmented ssRNA virus).
Recognizing the pathogen dictates the specific molecular mechanism of its infectious cascade.
2
Determine the initial event of viral infection.
The virus must first attach to the host cell via hemagglutinin binding to sialic acid.
Without surface receptor binding, the virus cannot initiate cellular entry.
3
Identify the method of cellular uptake.
The virus is internalized via receptor-mediated endocytosis.
Attachment triggers the host cell membrane to invaginate, trapping the virion in an endosome.
4
Trace the intracellular triggers for uncoating.
The endosome acidifies, leading to proton influx through the M2 channel and HA conformational changes.
The low pH environment is required to drive both the dissociation of internal viral proteins and the fusion of membranes.
5
Determine the final destination of the viral genome prior to replication.
The viral ribonucleoproteins (vRNPs) enter the host nucleus.
Unlike most RNA viruses, orthomyxoviruses replicate in the nucleus and require nuclear import of their genetic material.

Key Concept

Influenza virus entry and uncoating cascade
Estimated Time:1m 30s
Question 115Question →

A 72-year-old woman with a history of persistent atrial fibrillation presents to the emergency department 45 minutes after the sudden onset of right-sided hemiparesis and global aphasia. A non-contrast head CT shows no evidence of intracranial hemorrhage. She is diagnosed with an acute ischemic stroke in the territory of the left middle cerebral artery and is urgently evaluated for reperfusion therapy. At the cellular level, the sudden interruption of blood flow initiates a profound cascade of events in the ischemic penumbra that will ultimately lead to neuronal cell death if perfusion is not restored.

Arrange the following subcellular events in the chronological sequence they occur during the pathogenesis of excitotoxic neuronal injury in this patient, from the earliest initial event to the final terminal event.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with ATP depletion, followed by Na+/K+ pump failure, excessive glutamate release, NMDA receptor overstimulation, and finally massive intracellular calcium influx leading to enzyme activation.
In acute ischemic stroke, the immediate lack of oxygen completely halts oxidative phosphorylation, leading to a profound depletion of neuronal ATP. Neurons heavily rely on ATP to power the Na+/K+-ATPase pumps that maintain the resting membrane potential. When these pumps fail, the neuron rapidly depolarizes. This pathological depolarization opens presynaptic voltage-gated calcium channels, causing the uncontrolled release of the excitatory neurotransmitter glutamate into the synaptic cleft. The massive glutamate surge binds to and overstimulates postsynaptic NMDA and AMPA receptors. Because the NMDA receptor is a ligand-gated ion channel highly permeable to calcium, its overactivation allows a massive, lethal influx of extracellular calcium into the postsynaptic neuron. This calcium overload represents the 'point of no return', as it directly activates intracellular degradative enzymes—including proteases, lipases, and endonucleases—which dismantle structural proteins and cell membranes, leading to irreversible ischemic necrosis known as excitotoxicity.

Step-by-Step Solution

1
Identify the primary and immediate subcellular consequence of acute ischemia.
The first event is the cessation of oxygen delivery, which halts aerobic metabolism (oxidative phosphorylation) and causes a rapid depletion of intracellular ATP stores.
Neurons possess virtually no glycogen or oxygen reserves, making their ATP production completely dependent on continuous blood flow.
2
Determine the direct consequence of neuronal ATP depletion.
Failure of the ATP-dependent sodium-potassium (Na+/K+) pumps occurs.
The Na+/K+-ATPase pump consumes a massive portion of neuronal energy to maintain the electrochemical gradient. Lack of ATP causes immediate failure of this pump.
3
Trace the effect of pump failure on the neuronal membrane and neurotransmitter dynamics.
The cell membrane depolarizes, leading to the excessive vesicular release of glutamate into the synaptic cleft.
Loss of the resting membrane potential triggers voltage-gated channels in the presynaptic terminal, causing pathological, uncontrolled exocytosis of excitatory neurotransmitters.
4
Identify the direct target of the released neurotransmitter.
Overstimulation of postsynaptic NMDA and AMPA receptors.
Glutamate is the primary excitatory neurotransmitter in the central nervous system and floods its corresponding postsynaptic receptors.
5
Determine the terminal, lethal consequence of receptor overstimulation.
Massive intracellular calcium influx and subsequent activation of degradative enzymes.
The prolonged opening of NMDA receptors allows pathological amounts of calcium to flood the postsynaptic neuron. This calcium overload directly activates proteases, lipases, and endonucleases, cementing irreversible cellular necrosis.

Key Concept

Excitotoxicity in ischemic stroke follows a strict cascade: ischemia causes ATP depletion, leading to membrane pump failure and depolarization, which triggers massive glutamate release, NMDA receptor overstimulation, and ultimately a lethal intracellular influx of calcium.
Estimated Time:1m 30s
Question 116Question →

A 72-year-old man is evaluated in the emergency department for a massive hematoma on his right thigh that developed after a minor mechanical trauma. He has no prior personal or family history of bleeding disorders and has undergone multiple surgical procedures, including a cholecystectomy and prostatectomy, without excessive hemorrhage. His medical history includes hypertension, for which he takes lisinopril. Vital signs are within normal limits.

Laboratory studies show:
- Hemoglobin: 9.2 g/dL9.2 \text{ g/dL}
- Platelet count: 250,000/μL250,000/\mu\text{L}
- Prothrombin time (PT): 12 seconds12 \text{ seconds} (Normal: 11−14 seconds11-14 \text{ seconds})
- Activated partial thromboplastin time (aPTT): 78 seconds78 \text{ seconds} (Normal: 25−35 seconds25-35 \text{ seconds})

A mixing study is performed using normal pooled plasma. Immediately after mixing, the patient's aPTT corrects to 32 seconds32 \text{ seconds}. However, after incubating the mixture for 2 hours2 \text{ hours} at 37∘C37^\circ\text{C}, the aPTT prolongs again to 68 seconds68 \text{ seconds}.

Which of the following is the most likely primary mechanism underlying this patient's bleeding diathesis?

Show answer & explanation

Answer: Autoantibody-mediated neutralization of coagulation factor VIII

Answer

Autoantibody-mediated neutralization of coagulation factor VIII
The correct mechanism is autoantibody-mediated neutralization of coagulation factor VIII, which describes Acquired Hemophilia A. This condition typically presents in older adults or postpartum women as severe, sudden-onset bleeding without a prior bleeding history. The laboratory hallmark is an isolated prolonged aPTT. Because the factor VIII autoantibody's neutralizing activity is time- and temperature-dependent, a standard 1:1 mixing study with normal plasma may immediately correct the aPTT (as the normal plasma initially provides enough factor VIII). However, after incubating the mixture for 1 to 2 hours at 37∘C37^\circ\text{C}, the autoantibody has time to bind and neutralize the added factor VIII, causing the aPTT to prolong once again. This kinetic profile distinguishes it from simple factor deficiencies and most lupus anticoagulants.

Step-by-Step Solution

1
Analyze the clinical presentation.
An elderly patient with no prior bleeding history presents with a severe, spontaneous or minor-trauma-induced hemorrhage (massive hematoma).
This presentation strongly suggests an acquired bleeding diathesis rather than an inherited disorder (which would have manifested during prior surgeries).
2
Interpret the baseline laboratory values.
The patient has an isolated prolonged aPTT (78 seconds) with a normal PT and normal platelet count.
An isolated prolonged aPTT narrows the differential diagnosis to an intrinsic pathway defect, which can be either a factor deficiency (Factors VIII, IX, XI, XII) or the presence of an inhibitor (Lupus anticoagulant or specific factor autoantibody).
3
Interpret the kinetics of the mixing study.
The aPTT corrects immediately upon mixing but prolongs again after 2 hours of incubation at 37∘C37^\circ\text{C}.
Factor deficiencies correct immediately and remain corrected after incubation. Lupus anticoagulants typically fail to correct immediately. A time- and temperature-dependent inhibitor (initial correction followed by prolongation after incubation) is the classic hallmark of an acquired autoantibody against factor VIII (Acquired Hemophilia A).

Key Concept

Acquired Hemophilia A (Factor VIII inhibitor) diagnosis and mixing study interpretation
Question 117Question →

A 54-year-old man is maintained on an oral lipophilic beta-blocker for heart failure. The drug is eliminated exclusively via hepatic metabolism. It is completely absorbed across the gastrointestinal epithelium (fa=1.0f_a = 1.0) with no intestinal wall metabolism. Pharmacokinetic profiling reveals the drug has a baseline hepatic extraction ratio (EHE_H) of 0.800.80. The patient's hepatic blood flow (QQ) is estimated at 1,500 mL/min1,500 \text{ mL/min}.

The patient is subsequently diagnosed with latent tuberculosis and started on rifampin, a potent cytochrome P450 inducer. This induction increases the beta-blocker's hepatic intrinsic clearance (CLintCL_{int}) by exactly 50%50\%. Assuming the well-stirred model of hepatic clearance and that hepatic blood flow remains constant, what is the patient's new absolute oral bioavailability of the beta-blocker? Express your answer as a percentage rounded to one decimal place.

Show answer & explanation

Answer: 14.3

Answer

14.3
The drug's absolute oral bioavailability (FF) depends on the fraction absorbed (faf_a) and the fraction escaping hepatic extraction (1−EH1 - E_H). Because fa=1.0f_a = 1.0, F=1−EHF = 1 - E_H. For a high-extraction drug, intrinsic clearance (CLintCL_{int}) is much larger than hepatic blood flow (QQ). Using the well-stirred model equation EH=CLintQ+CLintE_H = \frac{CL_{int}}{Q + CL_{int}}, the initial CLintCL_{int} is calculated to be 6,000 mL/min6,000 \text{ mL/min}. A 50%50\% induction increases CLintCL_{int} to 9,000 mL/min9,000 \text{ mL/min}. Recalculating EHE_H yields 900010500=0.8571\frac{9000}{10500} = 0.8571. The new bioavailability is 1−0.8571=0.14281 - 0.8571 = 0.1428, which is 14.3%14.3\%. This non-linear shift illustrates why patients on high-extraction drugs are highly sensitive to enzyme induction during oral therapy.

Step-by-Step Solution

1
Calculate initial oral bioavailability (FF).
F=1−0.80=0.20F = 1 - 0.80 = 0.20
Since the drug is 100% absorbed (fa=1f_a = 1) without gut wall metabolism, systemic bioavailability depends purely on escaping first-pass hepatic extraction.
2
Calculate baseline intrinsic clearance (CLintCL_{int}).
CLint=6,000 mL/minCL_{int} = 6,000 \text{ mL/min}
Applying the well-stirred model (EH=CLintQ+CLintE_H = \frac{CL_{int}}{Q + CL_{int}}), we rearrange to solve for CLintCL_{int}: 0.80=CLint1500+CLint0.80 = \frac{CL_{int}}{1500 + CL_{int}}.
3
Determine the new CLintCL_{int} after CYP induction.
NewCLint=9,000 mL/minNew CL_{int} = 9,000 \text{ mL/min}
Rifampin induces the enzyme, increasing the baseline intrinsic clearance by 50%50\% (6000×1.56000 \times 1.5).
4
Calculate the new hepatic extraction ratio (EHE_H).
NewEH=90001500+9000=900010500≈0.8571New E_H = \frac{9000}{1500 + 9000} = \frac{9000}{10500} \approx 0.8571
We must substitute the new intrinsic clearance back into the well-stirred model equation, keeping blood flow (QQ) constant at 1500 mL/min1500 \text{ mL/min}.
5
Calculate final bioavailability (FF).
NewF=1−0.8571=0.142857  ⟹  14.3%New F = 1 - 0.8571 = 0.142857 \implies 14.3\%
The new systemic exposure is the fraction that escapes the newly elevated first-pass hepatic extraction.

Key Concept

Well-stirred model of hepatic clearance and first-pass effect
Question 118Question →

A 61-year-old man is admitted to the intensive care unit following an emergent exploratory laparotomy for a ruptured appendix. During the surgery, he experienced profound hemorrhagic shock, requiring massive fluid resuscitation and vasopressor support. On postoperative day 2, his urine output declines to 150 mL over 24 hours. Laboratory evaluation reveals a blood urea nitrogen of 72 mg/dL and a serum creatinine level of 4.3 mg/dL, elevated from a baseline of 0.9 mg/dL. Urinalysis is significant for the presence of numerous muddy brown granular casts, and the fractional excretion of sodium (FENa) is calculated at 2.8%. Renal ultrasonography reveals no evidence of urinary tract obstruction. The patient's acute renal dysfunction is primarily mediated by epithelial cell death. Which of the following subcellular mechanisms represents the critical point of transition to irreversible injury in these affected cells?

Show answer & explanation

Answer: Massive cytosolic calcium influx activating intracellular phospholipases and proteases

Answer

Massive cytosolic calcium influx activating intracellular phospholipases and proteases
The patient has acute tubular necrosis (ATN) secondary to prolonged intraoperative hypotension (ischemia), as evidenced by the muddy brown granular casts and a fractional excretion of sodium greater than 2%. At the cellular level, ischemic injury initially causes a reversible decrease in ATP production. However, if the ischemia persists, it leads to severe membrane dysfunction. The critical transition from reversible to irreversible cell damage is characterized by structural damage to the cell membrane and mitochondrial dysfunction. This allows a massive influx of extracellular calcium into the cytosol. The high intracellular calcium activates phospholipases (causing further membrane damage), proteases (leading to cytoskeletal breakdown), and endonucleases (causing nuclear chromatin fragmentation).

Step-by-Step Solution

1
Analyze the clinical history and laboratory findings.
The patient experienced profound hemorrhagic shock followed by oliguria, elevated creatinine, FENa > 2%, and muddy brown granular casts.
To establish the primary clinical diagnosis causing renal failure.
2
Correlate the clinical findings to a specific renal pathology.
The combination of an ischemic insult and muddy brown granular casts confirms the diagnosis of ischemic acute tubular necrosis (ATN).
To identify the organ-specific mechanism of injury.
3
Identify the cellular mechanism that defines irreversible injury in this condition.
Irreversible ischemic cell injury is characterized by severe membrane damage leading to massive calcium influx, which activates destructive intracellular enzymes.
To answer the specific question regarding the transition from reversible to irreversible cell injury.

Key Concept

In ischemic cell injury, the hallmark of the transition from reversible to irreversible damage is severe plasma and mitochondrial membrane damage, leading to massive cytosolic calcium influx and the activation of degradative enzymes (phospholipases, proteases, endonucleases).
Estimated Time:1m 30s
Question 119Question →

A 62-year-old man is evaluated in the surgical intensive care unit for worsening clinical status. Seven days ago, he underwent an exploratory laparotomy for a perforated appendix with peritonitis. Intra-abdominal fluid cultures obtained at the time of surgery grew *Enterobacter cloacae*. He was started on intravenous ceftriaxone based on the following initial susceptibility report:

AntimicrobialSusceptibility
CeftriaxoneSusceptible
CefepimeSusceptible
Piperacillin-tazobactamSusceptible
MeropenemSusceptible

Over the past 24 hours, the patient has developed recurrent fever, tachycardia, and increased vasopressor requirements. His temperature is 39.1°C (102.4°F). Physical examination shows a rigid, tender abdomen. A computed tomography scan of the abdomen reveals a new intra-abdominal fluid collection. The fluid is aspirated, and cultures again grow *Enterobacter cloacae*. Susceptibility testing of this new isolate reveals the following:

AntimicrobialSusceptibility
CeftriaxoneResistant
CefepimeSusceptible
Piperacillin-tazobactamResistant
MeropenemSusceptible

Which of the following is the most likely molecular mechanism responsible for this patient's treatment failure?

Show answer & explanation

Answer: De-repression of an inducible chromosomal cephalosporinase

Answer

The correct molecular mechanism responsible for this patient's treatment failure is the de-repression of an inducible chromosomal cephalosporinase.
The correct answer accurately describes the mechanism of AmpC beta-lactamase hyperproduction. Organisms in the SPICE-M group (Serratia, Providencia, indole-positive Proteus, Citrobacter, Enterobacter, and Morganella) possess a chromosomal ampC gene. Exposure to third-generation cephalosporins (like ceftriaxone) selects for mutant subpopulations that constitutively hyperproduce (de-repress) the AmpC enzyme. AmpC beta-lactamases hydrolyze first- through third-generation cephalosporins and are not inhibited by beta-lactamase inhibitors like tazobactam, explaining the new resistance to ceftriaxone and piperacillin-tazobactam. Cefepime and carbapenems remain stable against AmpC hydrolysis.

Step-by-Step Solution

1
Identify the pathogen and its inherent resistance potential based on the initial culture.
The pathogen is *Enterobacter cloacae*, a member of the SPICE-M group known for harboring inducible chromosomal AmpC beta-lactamase genes.
Understanding the intrinsic genetic traits of the isolated organism is crucial for predicting how it will respond to specific antibiotic classes over time.
2
Analyze the change in the susceptibility profile between the initial and subsequent isolates.
The isolate progressed from being pan-susceptible to being resistant against ceftriaxone and piperacillin-tazobactam, while maintaining susceptibility to cefepime and meropenem.
Identifying the specific pattern of newly acquired resistance helps pinpoint the exact molecular mechanism responsible for the clinical failure.
3
Correlate the clinical timeline, antibiotic exposure, and resistance pattern to the molecular mechanism.
Treatment with ceftriaxone (a 3rd-generation cephalosporin) selected for a derepressed mutant subpopulation that constitutively hyperproduces the AmpC cephalosporinase.
AmpC beta-lactamases are not inhibited by tazobactam, which explains the piperacillin-tazobactam resistance, but they do not effectively hydrolyze 4th-generation cephalosporins (cefepime) or carbapenems, which remain susceptible.

Key Concept

The emergence of resistance in SPICE-M organisms during treatment with third-generation cephalosporins is typically due to the selection of derepressed mutants that hyperproduce chromosomal AmpC beta-lactamases, which are not inhibited by beta-lactamase inhibitors.
Question 120Question →

An infection control consultation is requested for a 55-year-old male patient in the surgical intensive care unit who recently developed a catheter-related bloodstream infection. The patient was admitted three weeks ago following a high-speed motor vehicle collision that required multiple exploratory laparotomies and bowel resections. During his hospitalization, he received prolonged courses of empiric broad-spectrum antibiotics. Today, blood cultures drawn from his central venous catheter are positive for Gram-positive cocci arranged in pairs and short chains. The pathogen is confirmed to be highly resistant to both ampicillin and vancomycin. Which of the following molecular mechanisms most likely explains this pathogen's resistance to the glycopeptide antibiotic?

Show answer & explanation

Answer: Substitution of a terminal D-lactate for D-alanine in the peptidoglycan precursor

Answer

Substitution of a terminal D-lactate for D-alanine in the peptidoglycan precursor
The correct answer accurately describes the mechanism of vancomycin resistance in Enterococcus species. Vancomycin normally binds to the terminal D-alanyl-D-alanine of cell wall precursor peptides. Enterococci can acquire mobile genetic elements (vanA or vanB operons) that encode enzymes to synthesize precursors terminating in D-alanyl-D-lactate instead. This structural change removes a critical hydrogen bond, dramatically lowering vancomycin's binding affinity and conferring resistance.

Step-by-Step Solution

1
Identify the likely pathogen based on the clinical vignette and microbiological data.
The patient has a hospital-acquired infection with Gram-positive cocci in pairs and short chains, strongly suggesting Enterococcus species.
Enterococci commonly cause infections in patients with prolonged ICU stays, prior abdominal surgery, and heavy exposure to broad-spectrum antibiotics.
2
Analyze the specific resistance profile provided in the stem.
The pathogen is resistant to ampicillin and vancomycin, identifying it as Vancomycin-Resistant Enterococcus (VRE).
The question specifically asks for the mechanism of resistance to the glycopeptide antibiotic (vancomycin).
3
Recall the molecular mechanism of vancomycin resistance in VRE.
Resistance occurs via alteration of the terminal amino acids of the peptidoglycan precursor from D-alanyl-D-alanine to D-alanyl-D-lactate.
Vancomycin works by binding strongly to the D-alanyl-D-alanine terminus, inhibiting cell wall cross-linking. The D-alanyl-D-lactate alteration decreases vancomycin's binding affinity by a factor of 1,000, allowing cell wall synthesis to continue.

Key Concept

Vancomycin-Resistant Enterococcus (VRE) resistance mechanism
PreviousPage 6 / 22Next
Foundational Science and Mechanisms of Disease Practice Questions — USMLE Step 3 — Page 6 | Examkin